0001231919-19-000051.txt : 20190924 0001231919-19-000051.hdr.sgml : 20190924 20190924104420 ACCESSION NUMBER: 0001231919-19-000051 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190924 DATE AS OF CHANGE: 20190924 EFFECTIVENESS DATE: 20190924 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adjuvance Technologies Inc. CENTRAL INDEX KEY: 0001652786 IRS NUMBER: 270510244 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-349477 FILM NUMBER: 191109555 BUSINESS ADDRESS: STREET 1: 16 WEST 22ND STREET, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 2128459809 MAIL ADDRESS: STREET 1: 16 WEST 22ND STREET, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 D 1 primary_doc.xml X0708 D LIVE 0001652786 Adjuvance Technologies Inc. 2021 Transformation Drive Suite 1250 #2 Lincoln NV NEVADA 68508 4025872312 DELAWARE None None Corporation true Tyler Martin c/o Adjuvance Technologies Inc. 2021 Transformation Drive Suite 1250 #2 Lincoln NV NEVADA 68508 Executive Officer Director Isaac Cheng c/o Adjuvance Technologies Inc. 2021 Transformation Drive Suite 1250 #2 Lincoln NV NEVADA 68508 Director Ken Kelley c/o Adjuvance Technologies Inc. 2021 Transformation Drive Suite 1250 #2 Lincoln NV NEVADA 68508 Director Stephen Dilly c/o Adjuvance Technologies Inc. 2021 Transformation Drive Suite 1250 #2 Lincoln NV NEVADA 68508 Director Other Decline to Disclose 06b false 2019-08-29 false true false 0 24657194 10657192 14000002 false 28 0 0 0 false Adjuvance Technologies Inc. /s/ Tyler Martin Tyler Martin Chief Executive Officer 2019-08-29